Lipocalin, also known as Acrp30, is an adipocytokine that positively regulates glucose and lipid metabolism by increasing insulin sensitivity, stimulating fatty acid oxidation and glucose uptake, and inhibiting hepatic gluconeogenesis. Lipocalin deficiency is commonly associated with obesity and is highly correlated with insulin resistance, mitochondrial dysfunction and dyslipidemia.